The Sirolimus market on the other hand is more general referring to the global market in regard to the manufacture, distribution, and sales of the chemical compound sirolimus called rapamycin. Sirolimus is in the category of immunosuppressive drugs which are most commonly used in clients who have undergone transplantation and have organ rejection tendency and used in different types of cancer. It has involved stakeholder groups in the pharmaceutical industry including manufacturers and developers of sirolimus, investigation and research organizations, healthcare facilities and providers, and regulatory organizations. Limiting factors for this market include technological innovations, research and development projects, government dictates in health care, existing legislations, and the experience of organ transplantation and cancer across the globe.

Pregabalin is an anticonvulsant drug that belongs to the class of drugs called gamma-aminobutyric acid analogs and has been mainly used for the management of neuropathic pain, epilepsy, and generalized anxiety disorder.